Loading
LB
Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.) Stock: price and insider trades · Canada
Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.): what insiders have been doing
Every trade that managers of Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.) disclose to SEDI is tracked on this page. Nothing new has been filed by managers of Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.) in twelve months, the latest record being from 29 January 2021.
Our records for Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.) go back to 2016, with 54 purchases and 1 sale on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
64
Thresholds
n/a
Buy Volume
€60,142
54 ops. · all time
Sell Volume
€3,509
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 29 January 2021
Declarations64 total
16,000 shares@ CA$0.0670.2% of flowCommon SharesTSXSEDI:3670144
Canonical exit: 29 Apr 2021 (T+90)
31,600 shares@ CA$0.028Common SharesTSXSEDI:3625909
Canonical exit: 11 Feb 2021 (T+90)
69,000 shares@ CA$0.026Common SharesTSXSEDI:3621525
Canonical exit: 1 Feb 2021 (T+90)
1,700 shares@ CA$0.027Common SharesTSXSEDI:3621195
Canonical exit: 1 Feb 2021 (T+90)
20,700 shares@ CA$0.0268Common SharesTSXSEDI:3621010
Canonical exit: 31 Jan 2021 (T+90)
100,000 shares@ CA$0.025Common SharesTSXSEDI:3619437
Canonical exit: 27 Jan 2021 (T+90)
1,000 shares@ CA$0.025Common SharesTSXSEDI:3619754
Canonical exit: 27 Jan 2021 (T+90)
55,000 shares@ CA$0.025Common SharesTSXSEDI:3619314
Canonical exit: 26 Jan 2021 (T+90)
5,000 shares@ CA$0.0367Common SharesTSXSEDI:3605608
Canonical exit: 23 Dec 2020 (T+90)
150,000 shares@ CA$0.031Common SharesTSXSEDI:3603345
Canonical exit: 17 Dec 2020 (T+90)
357,000 shares@ CA$0.0276Common SharesTSXSEDI:3601968
Canonical exit: 14 Dec 2020 (T+90)
500,000 shares@ CA$0.024Common SharesTSXSEDI:3600071
Canonical exit: 9 Dec 2020 (T+90)
27,000 shares@ CA$0.02Common SharesTSXSEDI:3599551
Canonical exit: 8 Dec 2020 (T+90)
2,000 shares@ CA$0.02Common SharesTSXSEDI:3599549
Canonical exit: 7 Dec 2020 (T+90)
414,000 shares@ CA$0.024Common SharesTSXSEDI:3599550
Canonical exit: 8 Dec 2020 (T+90)
72,000 shares@ CA$0.0334Common SharesTSXSEDI:3595254
Canonical exit: 29 Nov 2020 (T+90)
44,000 shares@ CA$0.03860.3% of flowCommon SharesTSXSEDI:3587354
Canonical exit: 10 Nov 2020 (T+90)
128,000 shares@ CA$0.03860.9% of flowCommon SharesTSXSEDI:3586150
Canonical exit: 8 Nov 2020 (T+90)
100,000 shares@ CA$0.0390.7% of flowCommon SharesTSXSEDI:3584414
Canonical exit: 3 Nov 2020 (T+90)
28,000 shares@ CA$0.0350.2% of flowCommon SharesTSXSEDI:3582009
Canonical exit: 28 Oct 2020 (T+90)
100,000 shares@ CA$0.040.7% of flowCommon SharesTSXSEDI:3581641
Canonical exit: 27 Oct 2020 (T+90)
Common SharesTSXSEDI:3581314
16,760,000 shares@ CA$0.0538.2% of flowCommon SharesTSXSEDI:3565709
10,000 shares@ CA$0.03950.1% of flowCommon SharesTSXSEDI:3221922
Canonical exit: 8 Nov 2018 (T+90)
10,000 shares@ CA$0.0550.1% of flowCommon SharesTSXSEDI:3210345
Canonical exit: 8 Oct 2018 (T+90)
25 of 64 declarations
About Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.)
Lattice Biologics Ltd., formerly known as Blackstone Ventures Inc., is a company focused on developing biological products for regenerative medicine. It is listed on the Toronto Stock Exchange (XTSE).
